Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease

Authors

Gordon I Smith, Washington University School of Medicine in St. Louis
Mahalakshmi Shankaran, University of California - Berkeley
Mihoko Yoshino, Washington University School of Medicine in St. Louis
George G Schweitzer, Washington University School of Medicine in St. Louis
Maria Chondronikola, Washington University School of Medicine in St. Louis
Joseph W Beals, Washington University School of Medicine in St. Louis
Adewole L Okunade, Washington University School of Medicine in St. Louis
Bruce W Patterson, Washington University School of Medicine in St. Louis
Edna Nyangau, University of California - Berkeley
Tyler Field, University of California - Berkeley
Claude B Sirlin, University of California - San Diego
Saswata Talukdar, Merck & Co.
Marc K Hellerstein, University of California - Berkeley
Samuel Klein, Washington University School of Medicine in St. Louis

Journal

The Journal of Clinical Investigation

Publication Date

2020

Volume

130

Issue

3

First Page

1453

Last Page

1460

Document Type

Open Access Publication

DOI

10.1172/JCI134165

Rights and Permissions

Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. Gordon I. Smith, … , Marc K. Hellerstein, Samuel Klein. Journal of Clinical Investigation. 2020;130(3):1453-1460. Doi: 10.1172/JCI134165.

Recommended Citation

Smith, Gordon I; Shankaran, Mahalakshmi; Yoshino, Mihoko; Schweitzer, George G; Chondronikola, Maria; Beals, Joseph W; Okunade, Adewole L; Patterson, Bruce W; Nyangau, Edna; Field, Tyler; Sirlin, Claude B; Talukdar, Saswata; Hellerstein, Marc K; and Klein, Samuel, "Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease." The Journal of Clinical Investigation. 130, 3. 1453 - 1460. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/8963